Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3752.00 | 3320.50 | 1.1300 | 1.2766 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 3605.00 | 3320.50 | 1.0857 | 1.1821 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 2500.00 | 1726.92 | 1746.00 | 3320.50 | 0.5258 | 0.0117 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 2500.00 | 1726.92 | 3247.00 | 3320.50 | 0.9779 | 0.9531 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 2500.00 | 1726.92 | 3307.00 | 3320.50 | 0.9959 | 0.9914 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3413.00 | 3320.50 | 1.0279 | 1.0591 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 2500.00 | 1726.92 | 3050.00 | 3320.50 | 0.9185 | 0.8277 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 1772.00 | 3320.50 | 0.5337 | 0.0277 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3397.00 | 3320.50 | 1.0230 | 1.0489 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 1916.00 | 3320.50 | 0.5770 | 0.1165 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3332.00 | 3320.50 | 1.0035 | 1.0073 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 2803.00 | 3320.50 | 0.8442 | 0.6712 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 1320.00 | 3320.50 | 0.3975 | -0.2479 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 2500.00 | 1726.92 | 1251.00 | 3320.50 | 0.3768 | -0.2895 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3127.00 | 3320.50 | 0.9417 | 0.8767 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3299.00 | 3320.50 | 0.9935 | 0.9863 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5442.00 | 5488.75 | 0.9915 | 0.9776 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5326.00 | 5488.75 | 0.9704 | 0.9224 | |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 5000.00 | 3240.08 | 2024.00 | 5488.75 | 0.3688 | -0.4614 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5457.00 | 5488.75 | 0.9942 | 0.9848 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5444.00 | 5488.75 | 0.9919 | 0.9786 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 5000.00 | 3240.08 | 2568.00 | 5488.75 | 0.4679 | -0.2634 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5086.00 | 5488.75 | 0.9266 | 0.8093 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5639.00 | 5488.75 | 1.0274 | 1.0723 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 5000.00 | 3240.08 | 5413.00 | 5488.75 | 0.9862 | 0.9638 |